The Apobiologix Partnership Program
(The APP)
The Apobiologix Partnership Program (APP), launched in 2020, is an initiative focused on supporting our partners with a variety of important projects and programs that are meaningful to them.
The APP is focused on four main pillars that help optimize patient care and support excellence in Oncology:
1
Educational HCP Initiatives
This pillar is devoted to advancing educational initiatives that ultimately seek to improve patient care.
2
Educational Patient Resources
This pillar is dedicated to arming patients with information to better support them through their disease journey.
3
Grants & Projects
This pillar is focused on supporting projects and programs that aim to improve clinical understanding, drive sustainability of the healthcare system, or further efficiencies in the system.
4
Recognition, Awards & Value-Added Services
This pillar is focused on recognizing and awarding individuals who have made a significant contribution to their practice area. Additionally, it encompasses our patient support program - ANSWERS.
Download the APP newsletter to learn more about the program:
2022 July Edition |
2022 October Edition
For more information on the Apobiologix Partnership Program, contact your representative.
The APP is pleased to provide support for the HOPE Awards in Pharmacy. The HOPE (Honouring Oncology Pharmacy Excellence) Awards have been created by an independent Steering Committee of 5 Pharmacists to honor excellence in the practice of oncology pharmacy. Apobiologix, through the APP is proud to support three awards that recognize individuals or teams, who have made a significant contribution to oncology in different areas of practice
To learn more about the HOPE Awards in Pharmacy and how to apply,
please visit the HOPE website.
The APP is pleased to provide support for the ABC - An Oncology Pharmacy Education Program. The ABC Education Program has been created by an independent steering committee of 4 ncology pharmacists and is designed to provide oncology-specific pharmacy education through a 10-week ‘live’ course. Apobiologix, through the APP, is proud to support this program that facilitates broader pharmacy education and covers topics on the principles of cancer toxicity management and supportive care.
To learn more about the ABC - An Oncology Pharmacy Education Program, please email here.
Canadian Fellows Program at ASH*
The Canadian Fellows Program at ASH is monitored by independent Education Committee comprised of Hematologists from across Canada. Dr. Anargyros Xenocostas of London Health Sciences Centre is currently the Chair of the Hematology Award Program. The selection of the attendees will be made by a steering committee comprised of Hematologists from across Canada. Merit based selection will be made based upon a set of predetermined criteria.
The primary objectives of this program:
- To enhance the clinical and professional development of Fellows and Residents in the field of hematology and to allow trainees to meet with colleagues from across Canada.
- To identify and discuss key topics at ASH and have fellows provide their perspective and analysis
The program at ASH requires the selected Residents/Fellows to choose 2 abstracts/plenaries or educational sessions to attend and prepare to discuss at a meeting at ASH or virtually. The abstracts will not be in any way dictated by the sponsor - the fellows may choose whatever interests them. The meeting on Monday night will involve critical discussion of each abstract and will be chaired by two members of the selection committee.
The deadline for submitting a Fellow's application is mid-September.
Program attendees will be provided with a professional honoraria for their expertise.
For more information or should you have questions, please contact
Nirmesh Shah, VP, Medical Affairs
*Program not affiliated with ASH
Canadian Fellows Program at ASCO*
The Canadian Fellows Program at ASCO was initiated in June of 2003 and is monitored by independent Education Committee comprised of Medical Oncologists from across Canada. Dr. Stephen Chia of BC Cancer Centre currently is the Chair of the Oncology Award Program. The selection of the attendees will be made by a steering committee comprised of Medical Oncologists from across Canada. Merit based selection will be made based upon a set of predetermined criteria.
The primary objectives of this program:
- To enhance the clinical and professional development of Fellows and Residents in the field of oncology and to allow trainees to meet with colleagues from across Canada.
- To identify and discuss key topics at ASCO and have fellows provide their perspective and analysis.
The program at ASCO requires the selected Residents/Fellows to choose 2 abstracts/plenaries or educational sessions to attend and prepare to discuss at a meeting at ASCO or virtually. The abstracts will not be in any way dictated by the sponsor - the fellows may choose whatever interests them. The meeting on the Monday night of ASCO will involve critical discussion of each abstract and will be chaired by two members of the selection committee .
The deadline for submitting a Fellow’s application is mid-March.
Program attendees will be provided with a professional honorarium for their expertise.
For more information or should you have questions, please contact
Nirmesh Shah, VP, Medical Affairs
*Program not affiliated with ASCO